ABSTRACT
A novel locally manufactured and developed porous hydroxyapatite orbital implant has
been investigated and found to be as safe as commercially available implants.
Objective
To describe and analyze the results of twenty orbital implants implanted into patients in
one arm of a multicentre trial.
Methods
A porous hydroxyapatite orbital implant with a smooth cap was developed and implanted
into twenty patients. These patients were followed up for a period of four months.
Patients were examined for signs of infection or extrusion of the implants. The amount of
post-operative pain, chemosis, granuloma formation and vascularity was also assessed.
Results
None of the twenty patients had any signs of extrusion or infection at the termination of
the study. There was very little pain or chemosis noted and no granuloma formation.
Conclusion
The locally developed implants were safe in anophthalmic eyes when reviewed after a
four month follow-up period.
Identifer | oai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:wits/oai:wiredspace.wits.ac.za:10539/4926 |
Date | 04 June 2008 |
Creators | Levitz, Mark Lewis |
Source Sets | South African National ETD Portal |
Language | English |
Detected Language | English |
Type | Thesis |
Format | 229545 bytes, application/pdf, application/pdf |
Page generated in 0.0012 seconds